Show simple item record

dc.contributor.authorDahiya, Saurabh
dc.contributor.authorLuetkens, Tim
dc.contributor.authorLutfi, Forat
dc.contributor.authorAvila, Stephanie V.
dc.contributor.authorIraguha, Thierry
dc.contributor.authorMargiotta, Philip J
dc.contributor.authorHankey, Kim G.
dc.contributor.authorLesho, Patricia
dc.contributor.authorLaw, Jennie Y.
dc.contributor.authorLee, Seung Tae
dc.contributor.authorBaddley, John W.
dc.contributor.authorKocoglu, Mehmet Hakan
dc.contributor.authorYared, Jean
dc.contributor.authorHardy, Nancy M
dc.contributor.authorRapoport, Aaron P.
dc.contributor.authorAtanackovic, Djordje
dc.date.accessioned2022-01-19T16:25:27Z
dc.date.available2022-01-19T16:25:27Z
dc.date.issued2021-12-23
dc.identifier.urihttp://hdl.handle.net/10713/17617
dc.description.urihttps://doi.org/10.1182/bloodadvances.2021006112en_US
dc.language.isoenen_US
dc.publisherAmerican Society of Hematologyen_US
dc.relation.ispartofBlood Advancesen_US
dc.subjectHematologyen_US
dc.titleImpaired Immune Response to COVID-19 Vaccination in Patients with B-Cell Malignancies after CD19 CART Cell Therapyen_US
dc.typeArticleen_US
dc.identifier.doi10.1182/bloodadvances.2021006112
dc.source.journaltitleBlood Advances


This item appears in the following Collection(s)

Show simple item record